Drug profile · INN
fosfomycin disodium
CONTEPO
fosfomycin disodium (CONTEPO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — fosfomycin disodium
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
fosfomycin disodium (CONTEPO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is fosfomycin disodium?
fosfomycin disodium (CONTEPO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for fosfomycin disodium?
CONTEPO is a marketed brand name for fosfomycin disodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fosfomycin disodium?
fosfomycin disodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.